BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Aravive, Inc. (ARAV)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Aravive, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-14
10:24 am
Purchase		 2023-12-31 13G Aravive, Inc.
ARAV		 BIOTECHNOLOGY VALUE FUND L P 8,164,510
9.990%		 2,055,452increase
(+33.65%)		 Filing
2022-11-07
4:50 pm
Purchase		 2022-10-27 13G Aravive, Inc.
ARAV		 BIOTECHNOLOGY VALUE FUND L P 6,109,058
9.990%		 6,109,058increase
(New Position)		 Filing